Trump’s FDA pick faces MAHA resistance
Overton’s confirmation could set up a fight between the administration and part of President Donald Trump’s base.
President Donald Trump's selection of Heidi Overton to lead the Food and Drug Administration (FDA) has sparked resistance from some within the Make America Healthy Again (MAHA) movement. This development is expected to lead to a clash between the administration and a segment of the support base that contributed to Trump's second-term victory.
Alex Clark, a prominent online figure in the MAHA movement and a key supporter of Turning Point USA, recently urged his followers to oppose Overton's nomination. Clark accused her of having connections to major pharmaceutical companies, which has fueled the opposition. In response, White House spokesman Kush Desai stated that Overton did not author the February glyphosate executive order signed by Trump, but rather "pushed as many MAHA-minded edits as possible" to it.
Laura Loomer, another right-wing commentator, also criticized Overton as "another DEI hire." While not all members of the MAHA movement are opposed to Overton, the controversy has already sparked debate within the group.
Written by urgent.news from Semafor's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
